We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cell Differentiation Controlled by Two Related Proteins

By Biotechdaily staff writers
Posted on 29 Jul 2003
Researchers have identified the mechanism that controls whether hematopoetic stem cells (HSC) remain undifferentiated or whether they transform into one of eight specialized types of blood cells.

Investigators at the University of Wisconsin (Madison, USA) studied the interaction of the GATA transcription factors, which are known to be important determinants of cell fate during hematopoiesis. More...
They used chromatin immunoprecipitation analysis to show that the GATA-1 protein bound to a highly restricted upstream region of the 70-kb GATA-2 domain, despite the presence of more than 80 GATA sites throughout the domain. GATA-2 also bound to this region in the absence of GATA-1. Genetic complementation studies in GATA-1-null cells showed that GATA-1 rapidly displaced GATA-2, which was coupled to transcriptional repression. GATA-1 also displaced CREB-binding protein (CBP), despite the fact that GATA-1 bound CBP in other contexts. These findings were published July 11, 2003, in the online edition of the Proceedings of the National Academy of Sciences.

"Manipulations to expand stem cell numbers can cause the cells to lose their ability to remain stem cells,” explained senior author Dr. Emery Bresnick, professor of pharmacology at the University of Wisconsin. "Any mechanism that tells you how to maintain stem cell status and prevent differentiation is a good target for modulating and improving this whole process. We discovered a mechanism that is an excellent candidate for controlling the decision of whether the HSC should remain undifferentiated or form blood. It is a delicate balance between two highly related proteins, but if we can shift the balance by modulating this relationship, we can chose to increase the number of these limited HSC or stimulate hematopoiesis.”




Related Links:
University of Wisconsin

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Urine Analyzer
respons® UDS100
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.